Navigation Links
New Study Shows Tapentadol Extended Release (ER) May Significantly Reduce Average Pain Intensity for Diabetic Patients Suffering From Painful Peripheral Neuropathy
Date:1/28/2011

and osteoarthritic pain.  Also in the current study, the mean percentage of days on treatment with tapentadol ER that patients experienced nausea, vomiting, and constipation, respectively, was relatively low in both the open-label (8.8, 2.2 and 5.4 percent) and, particularly, in the double-blind (2.9, 1.0 and 1.9 percent) phases.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) and Grunenthal GmbH, conducted this study, which J&JPRD has included as part of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol ER tablets for the management of moderate to severe chronic pain in patients 18 years of age or older. The FDA currently is reviewing this application and, if approved, PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., will market tapentadol ER in the United States.

About tapentadolTapentadol is a centrally acting oral analgesic that binds to mu-opioid receptors and inhibits norepinephrine re-uptake. Although the exact mechanism of action is not known, these two mechanisms, which affect established pain pathways, are thought to be responsible for pain relief with tapentadol. The tapentadol molecule is classified as Schedule II of the Controlled Substances Act.

NUCYNTA® (tapentadol immediate release) was approved by the FDA on November 20, 2008, and is available by prescription only for the relief of moderate to severe acute pain in patients 18 years of age or older. On December 1, 2009, J&JPRD submitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets for the management of moderate to severe chronic pain in patients 18 years of age or older [http://www.jnj.com/connect/news/product/20091201_200000]. The tapentadol ER tablet formulation is designed to provide a high degree of mecha
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib (BSI-201) in Metastatic Triple-Negative Breast Cancer
2. US Army Study Shows STB Lifesaving Technologys® FAST® Dressing Superior to the Most Effective Currently Available Agents for Controlling Arterial Bleeding
3. Cetero Research Announces Completion of 20,000th Early-Phase Clinical Study
4. Surgeons at University of California San Diego Perform 1st TRAM Flap Procedure in an International Multi-Center Study Using TIGR® Matrix Surgical Mesh, the Worlds 1st Long-Term Resorbable Mesh
5. Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study
6. R-Tech Ueno Completes Phase 2a Clinical Study of RK-023 to Treat Androgenetic Alopecia
7. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
8. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump® and ResQPOD® CPR Devices
9. CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions
10. New Study on HIV/AIDS Redefines the Size, Scale, and Scope of Epidemic
11. Groundbreaking Study Showed Bayers Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution was the only Heartworm Preventive Tested That Demonstrated 100 Percent Efficacy against the Challenging MP3 Strain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)...  Regulatory leaders in the pharmaceutical industry continue to ... "21 st Century Cures." This ... by Congress soon and if enacted into law, it ... developed and marketed in the United States ... to consider how the proposed changes could impact their ...
(Date:4/17/2015)... 17, 2015 Nonin Medical, a global leader ... Chief Operating Officer Steve Bucholz will retire ... expanding his role as Chief Executive Officer. In addition, ... Technology Officer. Operations will transition to David Noel ... has been instrumental to Nonin Medical,s growth," Mr. ...
(Date:4/17/2015)... DUBLIN , Apr. 17, 2015 Research and ... addition of the "Medical Equipment Rental and Leasing ... offering. This report analyzes the worldwide markets ... The report provides separate comprehensive analytics for the US, ... , and Rest of World. Annual estimates ...
Breaking Medicine Technology:21st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2
... today launched a new program to help county residents deal ... with the National Association of Counties (NACo), the free Prescription ... offers an average of 24 percent savings off the retail ... be used by those who do not have insurance or ...
... Perrigo Company (Nasdaq: PRGO ; TASE) today ... quarter fiscal 2012 on Thursday, October 27, 2011 at approximately ... at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo,s ... will be available live via webcast to interested parties on ...
Cached Medicine Technology:Yamhill County Introduces Prescription Discount Card to Help Alleviate High Costs 2
(Date:4/19/2015)... (PRWEB) April 19, 2015 Family and friends ... for Brains in Memory of Brad Baddeley event to ... Aneurysm Foundation. , Bowling for Brains is cheduled to take ... 4700 Dudley Street in Lincoln, Nebraska. Participants may arrive at ... to 3:00pm. , The cost is only $4 per game ...
(Date:4/18/2015)... has released a new blog post explaining that ... a car accident. , Car insurance policies can ... can pay for car repairs and even medical expenses ... coverage when they are driving. , An ... riders that offer extra coverage options. One of the ...
(Date:4/18/2015)... 18, 2015 Review of Ophthalmology magazine ... ‘Strategies for Success’ program for cataract surgeons attending the ... San Diego, where eye surgeon Jeffrey L. Martin, MD ... event. Dr. Martin is the Managing Partner of North ... chose Dr. Martin to lead this year’s discussion on ...
(Date:4/18/2015)... York (PRWEB) April 18, 2015 Thousand ... filed on behalf of individuals who were allegedly harmed ... continue to move forward in the U.S. District Court, ... April 10th, the Court has amended an earlier Case ... cases. Among other things, the new amendment permits the ...
(Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch as part ... latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... In a turbulent world, people may find themselves in dangerous ... their first move, but some situations can be avoided if ...
Breaking Medicine News(10 mins):Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3Health News:A Personal Safety Application was Featured on NewsWatch Television 2
... vaccine to,prevent shingles was approved for use in 2006, ... age 60 and older who,previously had chickenpox. But two ... primarily affects adults with weakened immune,systems -- have left ... This uncertainty prompted a group of researchers led by,Barbara ...
... SWEDESBORO, N.J., Dec. 12 Yesterday, the U.S. ... vacated the Drug Enforcement,Administration,s (DEA) 2006 revocation of ... been challenging the DEA,s,decision since it first was ... company,s appeal of the,DEA,s decision and the DEA,s ...
... of trouble was 2 to 4 times greater than with ... -- Infants delivered by elective Caesarean section are up to ... born vaginally or by emergency C-section, says a Danish study ... British Medical Journal . , Researchers analyzed data on 34,000 ...
... (Dec. 12, 2007) -- Weill Cornell Medical College has ... & Melinda Gates Foundation to help fight tuberculosis, an ... kills nearly two million yearly -- mostly in the ... developing innovative TB drugs that are more effective than ...
... Officials Will Explain Regulatory Plans for Cutting-Edge,Technology at National ... 12 Nanotechnology was,incorporated into more than $50 billion ... 2014, the market will grow to $2.6 trillion.,By 2011, ... be,sold -- up from more than $3 billion in ...
... Dec. 12 Research that delivers,winning practices for improving ... management - is now available in the Best,Practice Database, ... Best Practices, LLC., To review sample key findings ... page with links to each study at this address:, ...
Cached Medicine News:Health News:Mayo Clinic Proceedings Article Offers New Data About the Impact of the Shingles Virus on Healthy Adults 2Health News:Mayo Clinic Proceedings Article Offers New Data About the Impact of the Shingles Virus on Healthy Adults 3Health News:Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action 2Health News:Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action 3Health News:Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action 4Health News:Elective Caesareans Raise Risk of Breathing Problems in Newborns 2Health News:Weill Cornell receives $2.4 million in grants from Gates Foundation to fight tuberculosis 2Health News:Weill Cornell receives $2.4 million in grants from Gates Foundation to fight tuberculosis 3Health News:Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy 2Health News:Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy 3Health News:Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor Major Conference on Nanotechnology Law, Regulation and Policy 4Health News:Best Practice Database Adds New Research on Contract Management and New Product Development 2
... two plastic parts that clamp a corneal ... the patient's cornea like a standard graft. ... since the 1960s and has gradually been ... About 600 implantations have been performed. It ...
A comprehensive CPT surgical, radiological and anesthesia coding reference....
Provides quick access to information needed to make diagnoses and treatment decisions....
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
Medicine Products: